Short Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Declines By 9.1%

Basilea Pharmaceutica AG (OTCMKTS:BPMUFGet Free Report) was the recipient of a large decline in short interest in May. As of May 31st, there was short interest totalling 74,900 shares, a decline of 9.1% from the May 15th total of 82,400 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 749.0 days.

Basilea Pharmaceutica Price Performance

Shares of OTCMKTS:BPMUF opened at $48.15 on Tuesday. Basilea Pharmaceutica has a one year low of $38.60 and a one year high of $48.15. The company’s 50-day moving average price is $45.78 and its two-hundred day moving average price is $42.38.

About Basilea Pharmaceutica

(Get Free Report)

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.

Featured Articles

Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.